"TBMC今天與將美國韌力公司簽署技術移轉與投資策略結盟協議，第1階段是TBMC取得美國韌力在生物製劑、疫苗、mRNA核酸藥物、細胞治療與基因療法等5大先進製程授權。"
https://ec.ltn.com.tw/article/breakingnews/4570366
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.
